Monique Hinchcliff

Summary

Affiliation: Northwestern University
Country: USA

Publications

  1. pmc Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis
    Monique Hinchcliff
    Department of Internal Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    J Invest Dermatol 133:1979-89. 2013
  2. pmc Text data extraction for a prospective, research-focused data mart: implementation and validation
    Monique Hinchcliff
    Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA
    BMC Med Inform Decis Mak 12:106. 2012
  3. pmc Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Clin Exp Rheumatol 30:S86-96. 2012
  4. pmc Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Clin Exp Rheumatol 30:S30-7. 2012
  5. pmc Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Arthritis Care Res (Hoboken) 63:1620-8. 2011
  6. ncbi request reprint Systemic sclerosis/scleroderma: a treatable multisystem disease
    Monique Hinchcliff
    Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Am Fam Physician 78:961-8. 2008
  7. pmc Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, McGaw Pavilion, Suite M300, 240 East Huron Street, Chicago, IL 60611, USA
    J Rheumatol 38:2172-9. 2011
  8. ncbi request reprint A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
    Jun Wei
    Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Ann Rheum Dis 73:446-54. 2014
  9. pmc Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?
    Jun Wei
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Arthritis Rheum 63:1707-17. 2011
  10. ncbi request reprint FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling
    Swati Bhattacharyya
    Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Sci Transl Med 6:232ra50. 2014

Collaborators

Detail Information

Publications17

  1. pmc Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis
    Monique Hinchcliff
    Department of Internal Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    J Invest Dermatol 133:1979-89. 2013
    ..Baseline gene expression in skin, including intrinsic subset assignment, may identify SSc patients whose MRSS will improve during MMF treatment, suggesting that gene expression in skin may allow targeted treatment in SSc...
  2. pmc Text data extraction for a prospective, research-focused data mart: implementation and validation
    Monique Hinchcliff
    Department of Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, USA
    BMC Med Inform Decis Mak 12:106. 2012
    ..To validate this package, we created a pulmonary function test data mart and analyzed the quality of the data mart versus manual chart review...
  3. pmc Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Clin Exp Rheumatol 30:S86-96. 2012
    ..Here we examined the effect of c-Abl activation and blockade in explanted healthy control and SSc fibroblasts...
  4. pmc Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Clin Exp Rheumatol 30:S30-7. 2012
    ..To determine the frequency, associated clinical factors, and prognostic significance of left ventricular (LV) diastolic dysfunction in systemic sclerosis (SSc)...
  5. pmc Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Arthritis Care Res (Hoboken) 63:1620-8. 2011
    ....
  6. ncbi request reprint Systemic sclerosis/scleroderma: a treatable multisystem disease
    Monique Hinchcliff
    Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Am Fam Physician 78:961-8. 2008
    ..Optimal patient care includes an integrated, multidisciplinary approach to promptly and effectively recognize, evaluate, and manage complications and limit end-organ dysfunction...
  7. pmc Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population
    Monique Hinchcliff
    Northwestern University Feinberg School of Medicine, McGaw Pavilion, Suite M300, 240 East Huron Street, Chicago, IL 60611, USA
    J Rheumatol 38:2172-9. 2011
    ..We describe the registry design and baseline characteristics of subjects enrolled during the first 18 months since the start of the study...
  8. ncbi request reprint A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses
    Jun Wei
    Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Ann Rheum Dis 73:446-54. 2014
    ..The synthetic oleanane triterpenoid, 2-cyano-3,12-dioxo-olean-1,9-dien-28-oic acid (CDDO), is a PPAR-γ agonist with potential effects on TGF-β signalling and dermal fibrosis...
  9. pmc Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?
    Jun Wei
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Arthritis Rheum 63:1707-17. 2011
    ....
  10. ncbi request reprint FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling
    Swati Bhattacharyya
    Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Sci Transl Med 6:232ra50. 2014
    ..Disrupting sustained TLR4 signaling therefore represents a potential strategy for the treatment of fibrosis in scleroderma. ..
  11. doi request reprint Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness
    Yasuji Mori
    Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    Exp Cell Res 314:1094-104. 2008
    ..To explore this notion, we characterized TGF-beta-induced activation of fibroblasts from CCN2-null (CCN2(-/-)) mouse embryos...
  12. ncbi request reprint Novel paradigm for treating vasculopathy in systemic sclerosis: vascular progenitor cells and statins
    Monique Hinchcliff
    Division of Rheumatology, Northwestern University Feinberg School of Medicine, McGaw Pavilion, 240 East Huron Street, Chicago, IL 60611 2909, USA
    Curr Rheumatol Rep 9:1-3. 2007
  13. ncbi request reprint Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets?
    John Varga
    Feinberg School of Medicine, Division of Rheumatology and Northwestern Scleroderma Program Northwestern University, 240 East Huron Street, Chicago, IL 60657, USA
    Nat Rev Rheumatol 10:200-2. 2014
    ..Categorizing patients improves disease management. A new study now proposes that patients with systemic sclerosis and overlapping features of another connective tissue disease might form a distinct disease subset...
  14. pmc Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry
    Sangmee Bae
    Department of Internal Medicine, University of California, Los Angeles, California, USA
    Ann Rheum Dis 71:1335-42. 2012
    ..The objectives of this analysis were to examine the baseline characteristics in systemic sclerosis (SSc) with normal and borderline mPAP and to explore long-term outcomes in SSc patients with borderline mPAP versus normal haemodynamics...
  15. ncbi request reprint Severe reversible left ventricular dysfunction associated with multiple cardiac myxomata
    Tomasz J Kuzniar
    Department of Medicine, Evanston Northwestern Healthcare, Evanston, IL, USA
    Wiad Lek 60:291-3. 2007
    ....
  16. pmc Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps
    Bruce K Tan
    Department of Otolaryngology Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    J Allergy Clin Immunol 128:1198-1206.e1. 2011
    ..Because high levels of BAFF are associated with autoimmune diseases, we assessed for evidence of autoimmunity in patients with CRS...
  17. ncbi request reprint Obliterative vasculopathy in systemic sclerosis: endothelial precursor cells as novel targets for therapy
    Monique Hinchcliff
    Northwestern University, Division of Rheumatology, Feinberg School of Medicine, McGaw 2300, 240 East Huron Street, Chicago IL, USA
    Expert Rev Clin Immunol 3:11-5. 2007
    ..Larger controlled trials are now needed to critically evaluate the efficacy of statins for repairing vascular damage, enhancing vasculogenesis, and attenuating the burden of chronic vasculopathy in SSc...